Logo image of NMS

NUVEEN MN QLTY MUNI INC (NMS) Stock Price, Quote, News and Overview

NYSE:NMS - New York Stock Exchange, Inc. - US6707341029 - Currency: USD

12.41  +0.04 (+0.32%)

Fundamental Rating

1

Taking everything into account, NMS scores 1 out of 10 in our fundamental rating. NMS was compared to 0 industry peers in the Unkown industry. NMS has a bad profitability rating. Also its financial health evaluation is rather negative. NMS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NMS had negative earnings in the past year.
In the past year NMS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NMS reported negative net income in multiple years.
Each year in the past 5 years NMS had a positive operating cash flow.
NMS Yearly Net Income VS EBIT VS OCF VS FCFNMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

1.2 Ratios

Industry RankSector Rank
ROA -2.49%
ROE -4.19%
ROIC 0.5%
ROA(3y)-0.83%
ROA(5y)0.58%
ROE(3y)-1.63%
ROE(5y)0.76%
ROIC(3y)1.36%
ROIC(5y)1.52%
NMS Yearly ROA, ROE, ROICNMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5

1.3 Margins

In the last couple of years the Operating Margin of NMS has declined.
In the last couple of years the Gross Margin of NMS has declined.
Industry RankSector Rank
OM 23.35%
PM (TTM) N/A
GM 25.15%
OM growth 3Y-26.62%
OM growth 5Y-18.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.03%
GM growth 5Y-18.45%
NMS Yearly Profit, Operating, Gross MarginsNMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for NMS remains at a similar level compared to 1 year ago.
The number of shares outstanding for NMS remains at a similar level compared to 5 years ago.
Compared to 1 year ago, NMS has a worse debt to assets ratio.
NMS Yearly Shares OutstandingNMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
NMS Yearly Total Debt VS Total AssetsNMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

NMS has an Altman-Z score of 0.83. This is a bad value and indicates that NMS is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of NMS is 12.24, which is on the high side as it means it would take NMS, 12.24 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.68 indicates that NMS is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 12.24
Altman-Z 0.83
ROIC/WACCN/A
WACCN/A
NMS Yearly LT Debt VS Equity VS FCFNMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 5.67 indicates that NMS has no problem at all paying its short term obligations.
A Quick Ratio of 5.67 indicates that NMS has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 5.67
Quick Ratio 5.67
NMS Yearly Current Assets VS Current LiabilitesNMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

NMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.45%, which is quite impressive.
The Revenue for NMS has decreased by -16.71% in the past year. This is quite bad
The Revenue for NMS have been decreasing by -11.09% on average. This is quite bad
EPS 1Y (TTM)60.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.5%
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-13.77%
Revenue growth 5Y-11.09%
Sales Q2Q%64.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NMS Yearly Revenue VS EstimatesNMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
NMS Yearly EPS VS EstimatesNMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NMS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NMS Price Earnings VS Forward Price EarningsNMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 17.65
EV/EBITDA N/A
NMS Per share dataNMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.15%, NMS is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.30, NMS pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.15%

5.2 History

The dividend of NMS decreases each year by -7.05%.
NMS has paid a dividend for at least 10 years, which is a reliable track record.
NMS has decreased its dividend recently.
Dividend Growth(5Y)-7.05%
Div Incr Years1
Div Non Decr Years1
NMS Yearly Dividends per shareNMS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of NMS are negative and hence is the payout ratio. NMS will probably not be able to sustain this dividend level.
DP-98.04%
EPS Next 2YN/A
EPS Next 3YN/A
NMS Yearly Income VS Free CF VS DividendNMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

More info and screens

NUVEEN MN QLTY MUNI INC

NYSE:NMS (2/20/2025, 2:16:01 PM)

12.41

+0.04 (+0.32%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.29%
Inst Owner Change26.13%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap71.85M
Analysts0
Price TargetN/A
Short Float %0.26%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield 6.15%
Yearly Dividend0.52
Dividend Growth(5Y)-7.05%
DP-98.04%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-14 2025-02-14 (0.0735)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.51
P/FCF 17.65
P/OCF 17.65
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY5.66%
OCF(TTM)0.7
OCFY5.66%
SpS0.58
BVpS12.61
TBVpS12.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.49%
ROE -4.19%
ROCE 0.64%
ROIC 0.5%
ROICexc 0.5%
ROICexgc 0.5%
OM 23.35%
PM (TTM) N/A
GM 25.15%
FCFM 121.86%
ROA(3y)-0.83%
ROA(5y)0.58%
ROE(3y)-1.63%
ROE(5y)0.76%
ROIC(3y)1.36%
ROIC(5y)1.52%
ROICexc(3y)1.37%
ROICexc(5y)1.53%
ROICexgc(3y)1.37%
ROICexgc(5y)1.53%
ROCE(3y)1.73%
ROCE(5y)1.93%
ROICexcg growth 3Y-34.24%
ROICexcg growth 5Y-26.22%
ROICexc growth 3Y-34.24%
ROICexc growth 5Y-26.22%
OM growth 3Y-26.62%
OM growth 5Y-18.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.03%
GM growth 5Y-18.45%
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 12.24
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.48
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.67
Quick Ratio 5.67
Altman-Z 0.83
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-13.77%
Revenue growth 5Y-11.09%
Sales Q2Q%64.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.42%
EBIT growth 3Y-36.73%
EBIT growth 5Y-27.89%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.59%
FCF growth 3Y2.4%
FCF growth 5Y15.15%
OCF growth 1Y-25.59%
OCF growth 3Y2.4%
OCF growth 5Y15.15%